Top

Published in:

01-04-2016 | Case report

Resection of liver metastasis derived from alpha-fetoprotein-producing gastric cancer—report of 4 cases

Authors: Yoh Asahi, Toshiya Kamiyama, Shigenori Homma, Kanako C. Hatanaka, Hideki Yokoo, Takahito Nakagawa, Hirofumi Kamachi, Kazuaki Nakanishi, Munenori Tahara, Tatsuhiko Kakisaka, Kenji Wakayama, Satoru Todo, Akinobu Taketomi

Published in: International Cancer Conference Journal | Issue 2/2016

Abstract

As is the case for metastatic liver tumors derived from standard gastric cancers, there is no consensus about the optimal treatment for metastatic liver tumors derived from alpha-fetoprotein (AFP)-producing gastric cancer, including regarding the surgical indications for such lesions. We report the cases of 4 patients in whom metastatic liver tumors derived from AFP-producing gastric cancer that were curatively resected. One of the patients had a thrombus in his inferior vena cava at the time of the liver resection, and both the liver tumor and thrombus were completely removed. The patient has survived 93 months after receiving multidisciplinary therapy including partial pneumonectomy, chemotherapy, and radiotherapy and currently has no evaluable disease. Another patient has survived for 3 years without suffering any recurrence. Since long-term survival is possible, liver resection should be considered as a treatment for liver metastases from AFP-producing gastric cancers.

Okita K, Noda K, Kodama T et al (1977) Carcino-fetal proteins and gastric cancer: the site of alpha-fetoprotein synthesis in gastric cancer. Gastroenterol Jpn 12:400–406PubMed

Chang YC, Nagasue N, Kohno H et al (1990) Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer. Am J Gastroenterol 85:1480–1485PubMed

Ishigami S, Natsugoe S, Nakashima H et al (2006) Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer. Hepatogastroenterology 53:338–341PubMed

Chang YC, Nagasue N, Abe S et al (1992) Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol 87:321–325PubMed

Kono K, Amemiya H, Sekikawa T et al (2002) Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg 19:359–365CrossRefPubMed

Liu X, Cheng Y, Sheng W et al (2010) Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases. J Surg Oncol 102:249–255CrossRefPubMed

Takemura N, Saiura A, Koga R et al (2012) Surgical indication and survival benefit of hepatectomy for gastric cancer liver metastasis (in Japanese). Gan To Kagaku Ryoho 39:2455–2459PubMed

Tsujimoto H, Ichikura T, Ono S et al (2010) Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol Int 4:406–413CrossRefPubMedPubMedCentral

Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma (2nd English edition). Gastric Cancer 1:10–24CrossRefPubMed

10.

Hirajima S, Komatsu S, Ichikawa D et al (2013) Liver metastasis is the only independent prognostic factor in AFP-producing gastric cancer. World J Gastroenterol 19:6055–6061CrossRefPubMedPubMedCentral

11.

Chang YC, Nagasue N, Abe S et al (1990) The characters of AFP-producing early gastric cancer. Nihon Geka Gakkai Zasshi 91:1574–1580PubMed

12.

Sun W, Liu Y, Shou D et al (2015) AFP aalpha fetoprotein: who are you in gastrology? Cancer Lett 357:43–46CrossRefPubMed

13.

Chun H, Kwon SJ (2011) Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer. J Gastric Cancer 11:23–30CrossRefPubMedPubMedCentral

14.

Tanizaki K, Nishioka K, Kobayashi K et al (2008) A case of AFP producing gastric cancer for which radiation therapy was effective in paraaortic lymphnode recurrence. Gan To Kagaku Ryoho 35:2048–2050PubMed

15.

Natsume T, Watanabe Y, Maruyama T et al (2005) Solitary pancreas metastasis from AFP-producing gastric cancer: report of a case. Hepatogastroenterology 52:1278–1280PubMed

16.

Ohdaira H, Murai R, Hanyu N et al (2007) Gastric cancer producing AFP/HCG which had rapidy orogressive course with metastasis to the brain discovered postoperatively (in Japanese). Nihon Shokakibyo Gakkai Zasshi 104:666–670PubMed

17.

Goda K, Tsunoda S, Sakaki T et al (1992) AFP producing gastric cancer manifested by metastasis to the tentorium cerebelli; case report and revew of the literature (in Japanese). No Shinkei Geka 20:183–185PubMed

18.

Nakahashi C, Kinoshita T, Konishi M et al (2004) Long-term survival achieved by repeated resections of metachronous pulmonary and adrenal metastases of alpha-fetoprotein-producing gastric cancer: report of a case. Surg Today 34:784–787CrossRefPubMed

19.

Kunoki N, Nishiyama R, Ryuzaki H et al (2008) A case of alpha-fetoprotein-producing gastric cancer with hepatic metastasis successfully treated with combination chemotherapy (in Japanese). Nihon Shokakibyo Gakkai Zasshi 105:1489–1495PubMed

20.

Takahashi T, Kochi M, Kanamori N et al (2009) Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer—report of a case (in Japanese). Gan To Kagaku Ryoho 36:1885–1888PubMed

21.

Yamamoto M, Niinobu T, Taniguchi H et al (2004) Three successful case reports of advanced gastric cancer with chemotherapy (in Japanese). Gan To Kagaku Ryoho 31:1689–1692PubMed

22.

Shiochi H, Yamada M, Kishina M et al (2009) A case of AFP-producing gastric cancer responding to the combination of systemic chemotherapy, transcatheter arterial embolization and hepatic infusion chemotherapy (in Japanese). Gan To Kagaku Ryoho 36:843–846PubMed

23.

Takada J, Kenno S, Aoki T et al (2009) A case in which intra-arterial chemotherapy for simultaneous hepatic metastases markedly improved AFP-producing gastric cancer (in Japanese). Gan To Kagaku Ryoho 36:2326–2329PubMed

24.

Nakamura H et al (2008) Combination of operation, chemotherapy and radiation for AFP producing gastric cancer—a case report (in Japanese). Gan To Kagaku Ryoho 35(2):299–301PubMed

25.

Yoshioka M, Inoue N, Someda H et al (2011) A case of AFP-producing gastric cancer resected after efficient S-1/CDDP combination chemotherapy (in Japanese). Gan To Kagaku Ryoho 38:105–108PubMed

26.

Hatta W, Kumagai S, Imamura J et al (2005) A case of curatively resected AFP producing gastric cancer that responded remarkably to 1 course of TS-1 and showed complete loss of multiple liver metastatic tumors (in Japanese). Gan To Kagaku Ryoho 32:855–858PubMed

27.

Kato M, Kinoshita K, Sawa T et al (1990) Early gastric cancer of type IIa+IIe producing α-fetoprotein with liver metastasis—report of a case (in Japanese). Nihon Shokaki Geka Gakkai Zasshi 23:2624–2628CrossRef

28.

Tsurumachi T, Yamamoto H, Watanabe K et al (1997) Resection of liver metasis from alpha-fetoprotein-producing early gastric cancer: report of a case. Surg Today 27:563–566CrossRefPubMed

29.

Sato Y, Nishimaki T, Date K et al (1999) Successful resection of metachronous liver metastasis from alpha-fetoprotein-producing gastric cancer: report of a case. Surg Today 29:1075–1078CrossRefPubMed

30.

Tajima G, Murase K, Kondo T et al (2004) A case of AFP producing gastric cancer with synchronous liver metastases mimicking hepatocellular carcinoma (in Japanese). Liver Cancer 10:178–188

31.

Tomono A, Wakahara T, Kanemitsu K et al (2013) A surgically resected case of AFP and PIVKA-II producing gastric cancer with hepatic metastasis (in Japanese). Nihon Shokakibyo Gakkai Zasshi 110:852–860PubMed

32.

Shibata Y, Sato K, Kodama M et al (2007) Alpha-fetoprotein-producing early gastric cancer of the remnant stomach: report of a case. Surg Today 37:995–999CrossRefPubMed

33.

Akune S, Saihara T, Ishigami S et al (2004) Successfully treated metachronous liver metastasis of alpha-fetoprotein-producing early gastric cancer: case report. Hepatogastroenterology 51:919–920PubMed

Title: Resection of liver metastasis derived from alpha-fetoprotein-producing gastric cancer—report of 4 cases
Authors: Yoh Asahi
Toshiya Kamiyama
Shigenori Homma
Kanako C. Hatanaka
Hideki Yokoo
Takahito Nakagawa
Hirofumi Kamachi
Kazuaki Nakanishi
Munenori Tahara
Tatsuhiko Kakisaka
Kenji Wakayama
Satoru Todo
Akinobu Taketomi
Publication date: 01-04-2016
Publisher: Springer Japan
Published in: International Cancer Conference Journal / Issue 2/2016
Electronic ISSN: 2192-3183
DOI: https://doi.org/10.1007/s13691-015-0236-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2016

Spontaneously metachronous ruptures of adrenocortical carcinoma and its contralateral adrenal metastasis

Marked improvement in leptomeningeal carcinomatosis and spinal cord metastases following alectinib treatment of crizotinib-resistant, ALK-positive lung adenocarcinoma

A case report of recurrent adult-onset xanthogranuloma: is the radiotherapy a treatment option?

A case of pulmonary granuloma associated with mycobacterium avium complex infection arising from the surgical margin after segmentectomy

Primary diffuse large B cell lymphoma of the common bile duct causing obstructive jaundice

Cryptogenic repetitive severe colitis after ileostomy closure

Keynote webinar | Spotlight on antibody–drug conjugates in cancer